TY - JOUR
T1 - Human organoids
T2 - A new dimension in cell biology
AU - Lehmann, Ruth
AU - Lee, Connie M.
AU - Shugart, Erika C.
AU - Benedetti, Marta
AU - Charo, R. Alta
AU - Gartner, Zev
AU - Hogan, Brigid
AU - Knoblich, Jürgen
AU - Nelson, Celeste M.
AU - Wilson, Kevin M.
N1 - Publisher Copyright:
© 2019 Lehmann et al.
PY - 2019
Y1 - 2019
N2 - Organoids derived from stem cells or tissues in culture can develop into structures that resemble the in vivo anatomy and physiology of intact organs. Human organoid cultures provide the potential to study human development and model disease processes with the same scrutiny and depth of analysis customary for research with nonhuman model organisms. Resembling the complexity of the actual tissue or organ, patient-derived human organoid studies may accelerate medical research, creating new opportunities for tissue engineering and regenerative medicine, generating knowledge and tools for preclinical studies, including drug development and testing. Biologists are drawn to this system as a new "model organism" to study complex disease phenotypes and genetic variability among individuals using patient-derived tissues. The American Society for Cell Biology convened a task force to report on the potential, challenges, and limitations for human organoid research. The task force suggests ways to ease the entry for new researchers into the field and how to facilitate broader use of this new model organism within the research community. This includes guidelines for reproducibility, culturing, sharing of patient materials, patient consent, training, and communication with the public.
AB - Organoids derived from stem cells or tissues in culture can develop into structures that resemble the in vivo anatomy and physiology of intact organs. Human organoid cultures provide the potential to study human development and model disease processes with the same scrutiny and depth of analysis customary for research with nonhuman model organisms. Resembling the complexity of the actual tissue or organ, patient-derived human organoid studies may accelerate medical research, creating new opportunities for tissue engineering and regenerative medicine, generating knowledge and tools for preclinical studies, including drug development and testing. Biologists are drawn to this system as a new "model organism" to study complex disease phenotypes and genetic variability among individuals using patient-derived tissues. The American Society for Cell Biology convened a task force to report on the potential, challenges, and limitations for human organoid research. The task force suggests ways to ease the entry for new researchers into the field and how to facilitate broader use of this new model organism within the research community. This includes guidelines for reproducibility, culturing, sharing of patient materials, patient consent, training, and communication with the public.
UR - http://www.scopus.com/inward/record.url?scp=85065260534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065260534&partnerID=8YFLogxK
U2 - 10.1091/mbc.E19-03-0135
DO - 10.1091/mbc.E19-03-0135
M3 - Article
C2 - 31034354
AN - SCOPUS:85065260534
SN - 1059-1524
VL - 30
SP - 1129
EP - 1137
JO - Molecular biology of the cell
JF - Molecular biology of the cell
IS - 10
ER -